In this podcast, Dr Michos, from Johns Hopkins University School of Medicine, talks about her latest study on how the influenza vaccine effects mortality and morbidity outcomes among patients with...
In this podcast, Temitope Ajibawo, MD, MPH, answers our questions about his team's study on how atrial fibrillation affects mortality and thromboembolic complications in patients who are hospitalized with...
In this podcast, Yoshihiro Tanaka, MD, PhD, answers our questions about his team's study on predicting bleeding risk among patients with atrial fibrillation who are taking direct oral anticoagulants instead...
In a recent study presented at the AHA’s Scientific Sessions, researchers examined the primary outcomes of number of deaths, adverse events, time to the first heart failure event, or a KCCQ score that had...
Since the optimal duration of dual antiplatelet therapy remains uncertain, researchers of a recent study examined a 1-month course of DAPT compared with 6 to 12-months of therapy following...
This direct-acting oral anticoagulant may be superior to the current standard of care anticoagulant for patients with a bioprosthetic mitral valve. In a study presented at AHA Scientific Sessions 2020,...
A reduction in cardiovascular events may be possible with the use of a new combination pill of blood-pressure- and cholesterol-lowering medications. In this trial, the researchers examined how this...
The researchers assessed the association between heart failure status at presentation for ACS and future ischemic events, rehospitalization for heart failure, and death 1 year after discharge from the...
In this podcast, Dr Michos, from Johns Hopkins University School of Medicine, talks about her latest study on how the influenza vaccine effects mortality and morbidity outcomes among patients with...
In this podcast, Temitope Ajibawo, MD, MPH, answers our questions about his team's study on how atrial fibrillation affects mortality and thromboembolic complications in patients who are hospitalized with...
In this podcast, Yoshihiro Tanaka, MD, PhD, answers our questions about his team's study on predicting bleeding risk among patients with atrial fibrillation who are taking direct oral anticoagulants instead...
In this podcast, Xiaoxi Yao, PhD, MPH, answers our questions about her team's research that investigated the use of anticoagulation and antithrombotic therapies in patients with atrial fibrillation,...
The new guidelines issued by the American Heart Association and the American College of Cardiology have essentially changed the definition of hypertension. What does this mean for your practice? Dr. Wilbert...
